OrthoPediatrics Corp (KIDS): Market Cap to Revenue

Symbol and logo of brand OrthoPediatrics Inc. (KIDS)

OrthoPediatrics Corp. relies on steady demand within the pediatric orthopedics segment, which remains insulated from market volatility. High-level management expertise and transparency in new product development ensure leadership within this niche. The growth strategy is based on the systematic acquisition of promising patents. The price-to-sales ratio dynamics on this chart demonstrate the market valuation of revenues, where 3.20 reflects the latest value of the metric.

KIDS OrthoPediatrics Inc. P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for OrthoPediatrics Corp. (KIDS)

- share price and consensus valuation forecast:
General company analysis:KIDS OrthoPediatrics Corp
Core merchandise of OrthoPediatrics

The P/S multiple determines the market value of a business relative to its annual revenue, allowing an investor to assess the premium paid for every dollar of sales. By analyzing the price-to-sales ratio, one can observe the stability of OrthoPediatrics Corp. (KIDS), whose biomedical supplies are protected by humanitarian status and neutrality, minimizing geopolitical risks and ensuring valuation resilience even during periods of global volatility.

Competitors of OrthoPediatrics Corp.

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple Treace Corp TMCI|Strata Critical Medical Inc - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|xtantmedical.com (XTNT) - Price-to-Revenue Ratio|Price to Sales n1mtc.com (NMTC)|Price-to-Revenue Ratio Modular Medical Inc|MYO: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue COCH (Envoy Medical, Inc)|Market Cap to Sales Volume VVOS|P/S Multiple NVNO (enVVeno Medical)|Market Capitalization-to-Revenue Ratio SINT|TNON - Price-to-Revenue Ratio|Price to Sales ReWalk Robotics|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price-to-Sales Ratio IVF (INVO Fertility Corp)|BBLG (Bone Biologics) - P/S Multiple|Price to Sales axonics.com AXNX|P/S Multiple BIOL|dynatronics.com - Market Cap to Revenue Ratio|P/S Multiple FNA (Paragon 28)|Price-to-Revenue Coefficient INVO Bioscience Inc. (INVO)